The Lung Pathology and Molecular Analysis Core (Core B) provides a powerful combination of experienced? and capable personnel whose primary role is to provide state of the art service and support to the research? investigators. To do this, the Core provides the technology and technical expertise to effectively supplement? the studies in lung cancer pathology, protein analysis, and microscopy described in this proposal. The major? objectives of this core are to (1) facilitate the acquisition, preservation, analysis, and dispersal of clinical? samples, (2) provide accurate histopathologic characterization of tumor tissues for all project investigators,? (3) allow access to state-of-the-art analytic protein chemistry and proteomics resources for use in the? identification, quantitation, and detailed structural characterization of proteins and protein complexes, and (4)? provide cutting-edge microscopy and imaging tools to ensure optimal visualization and analysis of cellular? processes. Specifically, Lung Pathology will develop and maintain a large repository of well-preserved, well-characterized? tissue specimens obtained from lung cancer patients that are receiving care or evaluation at? Emory University, or are participating in the Neoadjuvant Trial of Chemotherapy Hope (NATCH), to develop? unbiased comprehensive histologic characterization of the tissue samples used in each of the P-01 projects.? This Core also offers reliable centralized laboratory services to the investigators with respect to tissue? samples including state-of-the-art examination of immunohistochemical stains, in-situ hybridization microdissection,? and other techniques. It also serves as an important central database management resource to? maintain a comprehensive prospective, interactive database to provide access to patient demographic data? as well as detailed clinical pathologic data from patients with lung cancer. The protein analysis branch will? provide critical access to state-of-the-art analytical protein chemistry and proteomics resources for use in the? identification, quantitation, and detailed structural characterization of proteins and protein complexes as? needed. Lastly, the imaging facility will provide the necessary microscopy tools and technical expertise to? visualize the biological processes described in this application. Moreover, it will employ sophisticated image? analysis tools for image processing and accurate quantitative analyses. Taken together, the Lung Pathology? and Molecular Analysis Core serves as a critical resource that will facilitate scientific advancement through? lung pathology, protein-based initiatives, and microscopic analysis of cellular signaling pathways.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Emory University
United States
Zip Code
Shi, Zhi; Park, Hae R; Du, Yuhong et al. (2015) Cables1 complex couples survival signaling to the cell death machinery. Cancer Res 75:147-58
Shi, Z; Li, Z; Li, Z J et al. (2015) Cables1 controls p21/Cip1 protein stability by antagonizing proteasome subunit alpha type 3. Oncogene 34:2538-45
Kasinski, Andrea; Dong, Xueyuan; Khuri, Fadlo R et al. (2014) Transcriptional regulation of YWHAZ, the gene encoding 14-3-3?. PLoS One 9:e93480
Li, Zijian; Park, Hae Ryon; Shi, Zhi et al. (2014) Pro-oncogenic function of HIP-55/Drebrin-like (DBNL) through Ser269/Thr291-phospho-sensor motifs. Oncotarget 5:3197-209
Chen, Zhengjia; Cui, Ye; Owonikoko, Taofeek K et al. (2014) Escalation with overdose control using all toxicities and time to event toxicity data in cancer Phase I clinical trials. Contemp Clin Trials 37:322-32
Xiong, Fei; Jiang, Miao; Huang, Zhenzhou et al. (2014) A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells. Integr Cancer Ther 13:152-60
Mohamed, Amr; Deng, Xingming; Khuri, Fadlo R et al. (2014) Altered glutamine metabolism and therapeutic opportunities for lung cancer. Clin Lung Cancer 15:7-15
Koo, Junghui; Yue, Ping; Gal, Anthony A et al. (2014) Maintaining glycogen synthase kinase-3 activity is critical for mTOR kinase inhibitors to inhibit cancer cell growth. Cancer Res 74:2555-68
Sun, Shi-Yong (2013) Impact of genetic alterations on mTOR-targeted cancer therapy. Chin J Cancer 32:270-4
Li, Yikun; Wang, Xuerong; Yue, Ping et al. (2013) Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylation. J Biol Chem 288:13215-24

Showing the most recent 10 out of 64 publications